Gilead’s Strong Financials Marred by $1.25B ViiV Patent Settlement
Summary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute…
Summary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute…
Synopsis : The Budget had reduced cooperatives’ alternate minimum tax and charge. Meenesh Shah, Chairman, National Dairy Development Board had welcomed the…
Summary : Budget 2022 India Live, FM Nirmala Sitharaman Speech Live Updates: Speaking at a press conference after presenting the Union Budget,…
The prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact…
Synopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months,…
Summary : Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219…
Synopsis : Autonomous vehicle industry veteran will build on early success to lead operational growth, oversee geographic expansion, and spearhead Embark’s commercialization…
Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of…
Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed…
Summary : Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was…